This was successfully posted to your pofile.
This box will close automatically in a few seconds. Close this window
We don't have an e-mail address on file for you. To use AAFP Connection, you must have an e-mail address in our records. Click Here
'Shangai' Products Are Case in Point
NCCAM Materials Can Help You Discuss CAM With Patients
By News Staff
The products listed in the FDA advisory are Super Shangai; Strong Testis; Shangai Ultra; Shangai Ultra X; Lady Shangai; and Shangai Regular, also marketed as Shangai Chaojimengnan. They have been marketed for the treatment of ED and for sexual enhancement.
According to the advisory, the products are illegal drugs because they lack FDA approval.
Advisory Warns of Drug Interactions
Because men who use nitrates for these health conditions may have been advised to not take ED drugs, "they may seek out products like these because they are marketed as 'all natural' or as not containing the active ingredients in approved, prescribed ED drugs," says the advisory.
Kits Can Help Trigger CAM Discussion
Almost two-thirds of survey respondents reported they had used one or more CAM therapies, but fewer than one-third of those respondents said they had discussed their CAM use with their physicians. The top reason cited was that the doctor never asked (42 percent).
To encourage CAM discussions, NCCAM offers a free toolkit containing educational materials for physicians, their staff members and their patients. The kit includes a backgrounder; posters; tips for discussing CAM; and a patient wallet card for tracking medications, including CAM therapies. A "patient packet" is available as well. Both items may be ordered online or from the NCCAM Clearinghouse at (888) 644-6226. When ordering by phone, use reference code D392 for the health care professional toolkit; use code D393 when ordering the patient packet.
In general, NCCAM offers these CAM discussion tips for physicians:
- Include a question about CAM use on medical history forms.
- Ask patients to bring a list of all therapies they use, including prescription, over-the-counter and herbal products, and other CAM practices.
- Have medical staff, such as nurses or physician assistants, initiate the conversation.
This was successfully posted to your pofile.
This box will close automatically in a few seconds. Close this window
We don't have an e-mail address on file for you. To use AAFP Connection, you must have an e-mail address in our records. Click Here
Study: PPI Does Not Routinely Improve Asthma Control
Recalled Oral Contraceptives Pose Pregnancy Risk
CDC to Fund 2D Vaccine Barcoding Pilot
2012 Immunization Schedules Reflect Multiple Changes
Study: Cognitive Decline Detected in Middle-aged Adults
CDC Toolkit Can Help Clinicians Fight Norovirus Infection
Patient-Centered Care Linked to Lower Mortality
Study: Inappropriate Cancer Screenings Continue
Novartis Manufacturing Plant Closes After Drug Mix-ups
FDA Announces Classwide REMS for TIRF Medications
New Infants' Acetaminophen Products Hit Store Shelves
Avoid Environmental Factors Linked to Breast Cancer
Risk for Thrombosis Prompts REMS for Rivaroxaban
Common Drugs Implicated in Most Emergency Hospitalizations
CDC Launches Campaign for Child Medication Safety
HHS Blocks Expanded OTC Access to Plan B
Push Is On to Vaccinate Pregnant, Postpartum Women
FDA Committee Votes to Broaden PCV13 Indication
AAFP Foundation Program Aims to Fight Chronic Disease
NIAAA Alcohol Screening Guide Targets Teens
Walgreens, AAFP Launch Flu Vaccine Pilot in Five States
Helping Patients Quit Smoking Starts With a Question
Trilipix Efficacy in Question, Says FDA
USPSTF Addresses Skin Cancer, Obesity, Cervical Cancer Screening
AAFP Endorses ACP Guideline on ED
ACIP Recommends Expanded HPV, Hepatitis B Vaccination
Bacterial Contamination Spurs Nasal Spray Recall
CDC Renews Call for PCV13 Vaccination
USPSTF Recommends Against PSA Screening
AAFP Supports HHS' Million Hearts Initiative
FDA Phases Out Primatene Mist Inhalers
AHRQ Guides Explain Benefits, Risks of GERD Treatments
Office Champions Project Nets Smoking Cessation Gains
Multiple Lots of Oral Contraceptives Recalled
New Vaccine Review Finds Few Adverse Events
HPV Vaccination Rates Still Lag, Says CDC
Renal Injury Prompts Reclast Label Changes
High-dose Citalopram Linked to Abnormal Heart Rhythms
AHRQ Sleep Apnea Guides Review Diagnosis, Management
Board Chair Spotlights Breadth of Family Medicine Training
USPSTF Softens Stance on Bladder Cancer Screening
HHS Expands Coverage for Women's Preventive Services
Teledermatology Project Aids Underserved Patients
